‘Project Glass Box’ - UK Reveals Roadmap For AI Medtech Regulation
Executive Summary
The MHRA recently announced plans to review and reform how medical devices with AI or software components are to be regulated in the UK. Its new roadmap sheds light on how, exactly, it will deliver on these ambitions.
You may also be interested in...
What Regulators Want To See From AI And Software-Based Devices
Experts in software and AI medtech regulation from the UK’s MHRA have outlined the questions that device developers should seek to answer when preparing for the regulatory process.
News We’re Watching: UK Software Guidance, FDA Approvals, Halyard Mask Warning
Abbott landed a surprise US FDA approval for the FreeStyle Libre 3 glucose monitoring system. Also this week: updated guidance documents on software (UK) and angioplasty catheters (US), FDA clearances for Candesant and Moximed, new regulatory requirements for spinal spheres, and a warning on Halyard masks.
What The UK’s “Non-Statutory” AI Regulatory Framework Means For Medtech
The UK government has proposed a “pro-innovation” AI regulation strategy, which will utilize the expertise of existing regulators and avoid new legislation. But what does this mean for the medtech sector, and how does the UK approach differ from the EU’s AI Act?